Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Glioma × CLR1404 × Clear all

Phase

Status

Active not recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Magnetic Resonance Spectroscopy 4 Temozolomide 2 Aminolevulinic Acid 2 thymoglobulin 1 poly ICLC 1 pembrolizumab 1 pazopanib 1 orludodstat 1 keyhole-limpet hemocyanin 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1 fluciclovine F-18 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carbon-11 acetate 1 cabazitaxel 1 bicalutamide 1 azeliragon 1 auricularum 1 abemaciclib 1 Valproic Acid 1 Trail Making Test 1 Thiotepa 1 Tacrolimus 1 Sunitinib 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01778088 2014-02-25

Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma

Cellectar Biosciences, Inc.

Phase 2 Withdrawn

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡